Sequester Threatens FDA Mission
One aspect of sequestration isn’t doing anything to reduce the deficit, but could be delaying patient access to new drugs and medical devices, according to the FDA’s Janet Woodcock at a House...
View ArticleFDA Check-Up: Drug Development and Manufacturing Challenges
I have over 27 years of experience in the biotechnology and pharmaceutical industry. My current company, OncoMed Pharmaceuticals, is working at the cutting edge of oncology research, focused on...
View Article
More Pages to Explore .....
